Solid Biosciences
SLDB
71 hedge funds and large institutions have $46.9M invested in Solid Biosciences in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 11 closing their positions.
107% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $782K
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
3% more funds holding
Funds holding: 69 → 71 (+2)
0% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 22
0.04% less ownership
Funds ownership: 2.88% → 2.84% (-0.04%)
47% less capital invested
Capital invested by funds: $88.5M → $46.9M (-$41.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.78M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$1.65M |
| 3 |
JP Morgan Chase
New York
|
+$537K |
| 4 |
Two Sigma Advisers
New York
|
+$242K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$168K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.95M |
| 2 |
Morgan Stanley
New York
|
-$442K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$393K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$367K |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$358K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$133K | -1,987 | Closed |
|
77
Walleye Trading
New York
| – | -$98K | -1,467 | Closed |
|
|
AIM
78
Alambic Investment Management
Belvedere,
California
| – | -$78K | -1,164 | Closed |
|
|
TRCT
79
Tower Research Capital (TRC)
New York
| – | -$59K | -890 | Closed |
|
80
ProShare Advisors
Bethesda,
Maryland
| – | -$56K | -841 | Closed |
|
81
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$12K | -173 | Closed |
|
82
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -7 | Closed |
|
SLDB Hedge Fund Activity: Q1 2020 in Review
71 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2020, worth a combined $46.9M — down 47% from $88.5M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new SLDB positions and 11 closed out — a net gain of 3 holders — while 22 added to existing stakes and 22 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.78M. The largest seller was Millennium Management, cutting an estimated $2.95M.
- 71 institutional investors held Solid Biosciences (SLDB) as of Q1 2020, up from 69 in Q4 2019.
- Funds reported $46.9M of Solid Biosciences stock for Q1 2020, down 47% quarter-over-quarter.
- 14 funds opened new Solid Biosciences positions in Q1 2020 and 11 closed out, a net change of +3 holders.
- The largest Solid Biosciences buyer in Q1 2020 was Ikarian Capital, an estimated $1.78M added.
- The largest Solid Biosciences seller in Q1 2020 was Millennium Management, an estimated $2.95M sold.
Based on aggregated 13F filings for Q1 2020.